MedTrace Logo

SCP Hip Outcomes Study

NCT03494660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2026-04-21

Study results available
· View outcomes & findings →

Summary

Post-market clinical outcomes study to collect data on the short- and long-term outcomes for subjects who are undergoing or have undergone the Subchondroplasty® (SCP®) Procedure in the hip in a standard clinical setting. Outcomes to be assessed include medication usage, pain, function, activity levels and patient satisfaction.

Conditions

  • Subchondral Cysts
  • Subchondral Bone Edema
  • Bone Marrow Edema
  • Insufficiency Fractures
  • Avascular Necrosis of Hip
  • Femoroacetabular Impingement
  • Dysplasia; Hip

Interventions

DEVICE

Subchondroplasty Procedure with AccuFill

Injection of the commercially available flowable calcium phosphate (CaP) synthetic bone-void filler, AccuFill®, into subchondral bone defects in the hip (Subchondroplasty (SCP) Procedure).

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-27
Primary Completion
2023-10-23
Completion
2025-01-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03494660 on ClinicalTrials.gov